Correction: Honda et al. Visual Evaluation of Ultrafast MRI in the Assessment of Residual Breast Cancer After Neoadjuvant Systemic Therapy: A Preliminary Study Association with Subtype. Tomography 2022, 8, 1522-1533. [PDF]
TomographyHonda M +10 more
europepmc +1 more source
Inhibition of RNA polymerase II-activating CDK9 and CDK12/13, but not of cell cycle relevant CDKs, induces apoptosis by downregulating the short-lived Bcl-2 proteins Mcl1 and Bfl1/A1 [PDF]
Sebastian Wesselborg +15 more
openalex +1 more source
Interaction of Cx43 with Hsc70 regulates G1/S transition through CDK inhibitor p27 [PDF]
, 2015 Hitoshi Hino +7 more
openalex +1 more source
Focal Adhesion and Cancer Cell Cycle-Associated Resistance. [PDF]
ACS OmegaRuksha TG +3 more
europepmc +1 more source
High-resolution cryo-EM of the human CDK-activating kinase for structure-based drug design [PDF]
Victoria I. Cushing +12 more
openalex +1 more source
Efficacy of everolimus in patients with hormone receptor positive, HER2 negative, metastatic breast cancer pretreated with CDK4/6 inhibitors. [PDF]
Breast Cancer ResDutheil J +18 more
europepmc +1 more source
Cdk phosphorylation licenses Kif4A chromosome localization required for early mitotic progression [PDF]
, 2018 Zhixiong Dong +3 more
openalex +1 more source
Inactivation of CDK4/6, CDK2, and ERK in G1-phase triggers differentiation commitment. [PDF]
Commun BiolSharma S, Berger H, Meyer T, Teruel MN.
europepmc +1 more source
Influence of stage-specific and location-related intratumoral microbiota on prognosis and metabolic reprogramming in non-small cell lung cancer. [PDF]
Front ImmunolZhao Y +5 more
europepmc +1 more source
A Decade After Approval of the First CDK4/6 Inhibitor: A Look Back at Palbociclib's Journey from Discovery to Approval and What's Next in CDK Inhibition in Breast Cancer. [PDF]
Target OncolFinn RS +9 more
europepmc +1 more source